血塞通注射液联合阿托伐他汀钙治疗糖尿病合并脑梗死的临床效果

Abstract
Figure/Table
References (22)
Related Citation (15)

Download: PDF (0 KB) HTML (40 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of Xuesaitong Injection combined with Atorvastatin Calcium in the treatment of diabetes with cerebral infarction.Methods A total of 120 patients with diabetes with cerebral infarction admitted to our hospital from January 2017 to January 2019 were selected as the research objects.They were divided into the control group (n=60) and the observation group (n=60) according to the random number table method.Patients in the control group were treated with Atorvastatin Calcium alone, and patients in the observation group were treated with Xuesaitong Injection combined with Atorvastatin Calcium.The National Institute of Health stroke scale (NIHSS)score, plasma viscosity, whole blood high shear viscosity, hematocrit before and after treatment, total effective rate of treatment and incidence of adverse reactions were compared between the two groups.Results There was no significant difference in NIHSS score between the two groups before treatment (P＞0.05).The NIHSS score of the observation group after treatment was lower than that of the control group, and the difference was statistically significant (P＜0.05).The total effective rate of treatment in the observation group was 93.33%, which was higher than 68.33% in the control group,with statistical significance (P＜0.05).There were no statistically significant differences in plasma viscosity, high blood viscosity and hematocrit before treatment between the two groups (P＞0.05).After treatment, the plasma viscosity, high blood viscosity and hematocrit in the observation group were lower than those in the control group, with statistical significances (P＜0.05).There was no significant difference in the total incidence rate of adverse reactions between the two groups (P＞0.05).Conclusion Combined treatment of Xuesaitong Injection and Atorvastatin Calcium in diabetic patients with cerebral infarction can effectively improve nerve function, enhance curative effect, improve blood viscosity, avoid adverse reactions, and increase safety.

Key words： Xuesaitong Injection Atorvastatin Calcium Diabetes Cerebral infarction High blood viscosity;Plasma viscosity

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZENG Xiao-hua
	HUANG Wen

Cite this article:

ZENG Xiao-hua,HUANG Wen. Clinical effect of Xuesaitong Injection combined with Atorvastatin Calcium in the treatment of diabetes with cerebral infarction[J]. 中国当代医药, 2020, 27(22): 44-47.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I22/44

[1]	戴丽.血塞通联合左旋氨氯地平治疗脑梗死并高血压患者的疗效观察[J].中国实用神经疾病杂志，2016，19（12）：119-120.
[2]	王丙聚，韩晓芳，郭爱红，等.阿托伐他汀钙联合血塞通注射液对糖尿病合并脑梗死患者血液流变指标和神经功能的影响[J].陕西医学杂志，2017，46（4）：533-534.
[3]	李雪花，黄盛新，余天强，等.丹红注射液联合阿托伐他汀钙治疗糖尿病合并脑梗死的疗效观察[J].广西医学，2018，40（9）：1009-1011，1033.
[4]	廖文明，邓珊珊.注射用血栓通联合阿托伐他汀钙治疗糖尿病合并脑梗死效果及对患者神经功能的影响研究[J].中外医学研究，2019，17（1）：131-132.
[5]	袁勇.血塞通注射液联合瑞舒伐他汀治疗糖尿病合并脑梗死疗效及对患者神经功能的影响[J].中国实用医药，2017，12（16）：4-6.
[6]	王辉，李燕，孙梅，等.前列地尔注射液联合注射用血塞通治疗2 型糖尿病合并急性脑梗死120 例疗效观察[J].中国实用神经疾病杂志，2016，19（19）：90-92.
[7]	郭东青.血塞通联合西医抗血小板治疗脑梗死患者的疗效及对血脂代谢的影响[J].中国实用神经疾病杂志，2016，19（19）：84-85.
[8]	张江霞.丁苯酞软胶囊联合血塞通治疗脑梗死的疗效观察[J].中国实用神经疾病杂志，2016，19（15）：118-119.
[9]	张会，徐祥辉.血塞通治疗脑梗死的效果评估[J].中国实用神经疾病杂志，2017，20（11）：127-128.
[10]	李明初，廖长琦，杨晓平.血塞通注射液联合阿托伐他汀钙治疗糖尿病合并脑梗死疗效及对患者神经功能的影响[J].中国现代医学杂志，2015，25（31）：49-52.
[11]	Goto Y，Kumura E，Watabe T，et al.Prediction of Malignant Middle Cerebral Artery Infarction in Elderly Patients[J].J Stroke Cerebrovasc Dis，2016，25（6）：1389-1395.
[12]	Schaefer PW，Pulli B，Copen WA，et al.Combining MRI with NIHSS thresholds to predict outcome in acute ischemic stroke：value for patient selection[J].AJNR Am J Neuroradiol，2015，36（2）：259-264.
[13]	叶冬英，石斌，林琳.血塞通辅助高压氧治疗对脑梗死患者的血液动力学及神经功能的影响[J].世界中西医结合杂志，2018，13（1）：74-76，80.
[14]	裴琴.2 型糖尿病合并急性脑梗死患者行前列地尔注射液联合注射用血塞通治疗的临床效果及预后研究[J].中国实用医药，2019，14（26）：51-53.
[16]	黄靓，陆邦超，陈晓琳，等.血塞通联合阿托伐他汀钙对糖尿病伴脑梗死神经功能的影响[J].西北药学杂志，2019，34（1）：109-112.
[18]	韩军辉.阿托伐他汀钙治疗急性期缺血性脑卒中的效果[J].中国当代医药，2019，26（25）：49-51.
[19]	谢卫民.阿托伐他汀钙治疗脑梗死的临床疗效及安全评价[J].当代医学，2019，25（26）：18-20.
[20]	邢贞国.阿托伐他汀钙片治疗急性脑梗死患者神经功能缺损的影响及疗效观察[J].中国医药科学，2019，9（12）：232-234.
[15]	Li WT，Shafi N，Periakaruppan R，et al.Cerebral Aspergillosis in a Diabetic Patient Leading to Cerebral Artery Occlusion and Ischemic Stroke：A Case Report and Literature Review[J].J Stroke Cerebrovasc Dis，2015，24（1）：e39-e43.
[17]	Kazanci SY，Yesilbas O，Ersoy M，et al.Cerebral infarction and femoral venous thrombosis detected in a patient with diabetic ketoacidosis and heterozygous factor ⅤLeiden G1691A and PAI-1 4G/5G mutations[J].J Pediatr Endocrinol Metab，2015，28（9-10）：1183-1186.
[21]	桂树华，胡玲玲，王挺刚，等.血塞通软胶囊联合阿司匹林治疗老年慢性脑梗死对颈动脉斑块稳定性及机体抗氧化功能的影响[J].贵州医药，2017，41（10）：1059-1061.
[22]	邓尧宇，龙贤齐.血塞通联合施慧达对脑梗死并发高血压患者的血压水平及神经缺损修复的效果[J].血栓与止血学，2017，23（6）：983-985.